Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD
Sonnal Lohia(Biomedical Research Foundation of the Academy of Athens), Antonia Vlahou(Academy of Athens), Vasiliki Lygirou(Biomedical Research Foundation of the Academy of Athens), Francis Verbeke(Ghent University Hospital), Manousos Makridakis(Academy of Athens), Griet Glorieux(Ghent University Hospital), Jérôme Zoidakis(Academy of Athens), Sophie Valkenburg(Ghent University Hospital), Rafael Stroggilos(Biomedical Research Foundation of the Academy of Athens)
Cited by 5
Related Papers
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
|iScience|2021|116
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
|Nature Reviews Nephrology|2022|112
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
|Clinical Cancer Research|2016|104